University of Alaska Fiscal Foundation Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
99pct
525d open
vs 5,357 other S bills in the 117th — cohort avg 38d
University of Alaska Fiscal Foundation Act This bill directs the Bureau of Land Management (BLM) to establish a program to identify and convey available federal land in Alaska to the University of Alaska for a land grant to support higher education. The bill also permits the BLM or the Department of Agriculture to acquire by purchase or exchange, with the university's consent, university-owned inholdings within conservation system units. Any land exchanged shall be of equal value. No later than four years after enactment of the bill, Alaska and the university may jointly identify no more than 500,000 acres of land for inclusion in the program, of which not more than 360,000 acres may be conveyed and patented to the university. Upon the request of Alaska and the university, the BLM shall provide technical assistance in the identification of land. If Alaska and the university notify the BLM in writing that Alaska and the university jointly concur with the conveyance of all or a portion of the land identified for conveyance, and that Alaska relinquishes its selection rights to the land covered by the notification, the BLM shall convey the land to the university, to be held in trust for the exclusive use and benefit of the university. The BLM shall notify Congress of the land conveyed and patented.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2023 · second_quarter · Health Issues
Placed on Senate Legislative Calendar under General Orders. Calendar No. 495.
Committee on Energy and Natural Resources. Reported by Senator Manchin with an amendment in the nature of a substitute. With written report No. 117-152.
Committee on Energy and Natural Resources. Ordered to be reported with an amendment in the nature of a substitute favorably.
Committee on Energy and Natural Resources Subcommittee on Public Lands, Forests, and Mining. Hearings held.
Read twice and referred to the Committee on Energy and Natural Resources.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act H.R.2666 - Medicaid MVP for Patients Act S.652 / H.R.2630 - Safe Step Act H.R.2679 - Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act S.1339 - Pharmacy Benefit Manager Reform Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.4011 - Timely Access to Clinical Treatment Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S. 1375 / H.R.830 - Help Ensure Lower Patient (HELP) Copays Act S.954 / H.R.1488 - Affordable Insulin Now Act H.R.1503 - Prescription Information Modernization Act H.R.1352 - Increasing Access to Biosimilars Act S.1374 - Patient Right to Shop Act H.R.3799 - CHOICE Arrangement Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.574 - Increasing Prescription Drug Competition Act S.775 - Increasing Transparency in Generic Drug Applications Act H.R.1790 - Biologics Competition Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1522 - A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration
Client expense: $3,402,542 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · second_quarter · Health Issues
H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 830/ S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2500: Protecting Americans from Unsafe Drugs Act of 2023 H.R. 2679: Pharmacy Benefit Manager Accountability Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2940/S 1355 PASTEUR Act/Incentives to increase novel antibiotic medicines H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3008: Drug Shortage Prevention Act of 2023 H.R. 3281: Transparent PRICE Act H.R. 3285: Fairness for Patient Medications Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program/Transparency Legislation H.R. 3433: Give Kids a Chance Act of 2023 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3791: Improving DATA in Public Health Act H.R. 3793: Ensuring Access to Lifesaving Drugs Act of 2023 H.R. 3810: Drug Origin Transparency Act of 2023 H.R. 4390: Protect 340B Act - Provisions related to 340B Program (117th Congress) H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169)/Implementation of $0 Vaccine co-pay; maximum fair price provisions H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022 - This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why) (117th Congress) H.R. 7653: Modern Authentication of Pharmaceuticals Act of 2022 (117th Congress) S. 6: Biosimilar Red Tape Elimination Act (117th Congress) S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 315: Taxpayer Research And Contributions Knowledge Act of 2023 or TRACK Act of 2023 - To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development, and for other purposes. S. 476: Maintaining Investments in New Innovation Act S. 775: Increasing Transparency in Generic Drug Applications Act S. 1128: Ensuring Access to Generic Medications Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 - Provisions related to drug pricing (117th Congress) S. 1967: Patients Before Middlemen (PBM Act) S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1114: Expanding Access to Low-Cost Generics Act 2023 S. 1214: RARE Act - To set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1355: PASTEUR Act of 2023 - Provisions related to antimicrobial resistance policy issues S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act (117th Congress) Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance (AMR) policy issues Mental health policy issues High deductible health plans/HSA policy issues Supply chain policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Defense Production Act policy issues Cybersecurity policy issues Anticounterfeiting policy issues Chronic Kidney Disease Improvement in Research and Treatment Act. H.R.2534 - PROTECT 340B Act of 2023 House Draft Language for PAHPA Reauthorization HR 3665 - Defending American Jobs and Investment Act Senate Draft Language for PAHPA Reauthorization Pandemic and All Hazards Preparedness Act reauthorization (discussion draft) Labor HHS appropriations (ongoing discussion) Under Taxed Profit Rule, Ways and Means Committee discussion Vaccine Injury Compensation Program reform discussion
Client expense: $900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2023 · second_quarter · Health Issues
H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 830: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2500: Protecting Americans from Unsafe Drugs Act of 2023 H.R. 2534: PROTECT 340B Act of 2023 - Provisions related to the 340B program H.R. 2679: Pharmacy Benefit Manager Accountability Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3008: Drug Shortage Prevention Act of 2023 H.R. 3281: Transparent PRICE Act H.R. 3285: Fairness for Patient Medications Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3433: Give Kids a Chance Act of 2023 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3791: Improving DATA in Public Health Act H.R. 3793: Ensuring Access to Lifesaving Drugs Act of 2023 H.R. 3810: Drug Origin Transparency Act of 2023 H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169) H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022 (117th Congress) H.R. 7653: Modern Authentication of Pharmaceuticals Act of 2022 (117th Congress) S. 6: Biosimilar Red Tape Elimination Act (117th Congress) S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 315: Taxpayer Research And Contributions Knowledge Act of 2023 or TRACK Act of 2023 - To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development, and for other purposes S. 476: Maintaining Investments in New Innovation Act S. 775: Increasing Transparency in Generic Drug Applications Act S. 1128: Ensuring Access to Generic Medications Act S. 935: Fair Accountability and Innovative Research Drug Pricing Act of 2023 - Provisions related to drug pricing S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1114: Expanding Access to Low-Cost Generics Act 2023 S. 1214: RARE Act - To set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1355: PASTEUR Act of 2023 - Provisions related to antimicrobial resistance policy issues S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act (117th Congress) Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance (AMR) policy issues Mental health policy issues High deductible health plans/HSA policy issues Supply chain policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Defense Production Act policy issues Cybersecurity policy issues Anticounterfeiting policy issues
Client expense: $6,300,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2022 · fourth_quarter · Real Estate/Land Use/Conservation
H.R. 2546, University of Alaska Fiscal Foundation Act, supporting passage of the bill. S. 1128, University of Alaska Fiscal Foundation Act, supporting passage of the bill.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Real Estate/Land Use/Conservation
H.R. 2546, University of Alaska Fiscal Foundation Act, supporting passage of the bill. S. 1128, University of Alaska Fiscal Foundation Act, supporting passage of the bill.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Real Estate/Land Use/Conservation
H.R. 2546, University of Alaska Fiscal Foundation Act, supporting passage of the bill. S. 1128, University of Alaska Fiscal Foundation Act, supporting passage of the bill.
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Real Estate/Land Use/Conservation
H.R. 2546, University of Alaska Fiscal Foundation Act, supporting passage of the bill. S. 1128, University of Alaska Fiscal Foundation Act, supporting passage of the bill.
Client expense: $65,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Real Estate/Land Use/Conservation
H.R. 2546, University of Alaska Fiscal Foundation Act. S. 1128, University of Alaska Fiscal Foundation Act.
Client expense: $100,000 · Firm income: Not reported
Government targets: Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2022 · second_quarter · Real Estate/Land Use/Conservation
H.R. 2546, University of Alaska Fiscal Foundation Act S. 1128, University of Alaska Fiscal Foundation Act
Client expense: $110,000 · Firm income: Not reported
Government targets: Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2022 · first_quarter · Real Estate/Land Use/Conservation
H.R. 2546, University of Alaska Fiscal Foundation Act S. 1128, University of Alaska Fiscal Foundation Act
Client expense: $60,000 · Firm income: Not reported
Government targets: Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2022 · third_quarter · Real Estate/Land Use/Conservation
H.R. 2546, University of Alaska Fiscal Foundation Act. S. 1128, University of Alaska Fiscal Foundation Act.
Client expense: $100,000 · Firm income: Not reported
Government targets: Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2022 · second_quarter · Real Estate/Land Use/Conservation
H.R. 2546, University of Alaska Fiscal Foundation Act S. 1128, University of Alaska Fiscal Foundation Act
Client expense: $110,000 · Firm income: Not reported
Government targets: Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2022 · first_quarter · Real Estate/Land Use/Conservation
H.R. 2546, University of Alaska Fiscal Foundation Act S. 1128, University of Alaska Fiscal Foundation Act
Client expense: $60,000 · Firm income: Not reported
Government targets: Bureau of Land Management (BLM), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2021 · fourth_quarter · Environment/Superfund
S. 282, Arctic Refuge Protection Act, all provisions -This bill designates approximately 1,559,538 acres of land within Alaska in the Arctic National Wildlife Refuge (ANWR) as a component of the National Wilderness Preservation System. S. 1128, University of Alaska Fiscal Foundation Act, all provisions -This bill provides for the continuation of higher education through the conveyance to the University of Alaska of certain public land in the State of Alaska, and for other purposes. H.R. 815, Arctic Refuge Protection Act, all provisions -This bill amends Public Law 115-97 (commonly known as the Tax Cuts and Jobs Act) to repeal the Arctic National Wildlife Refuge oil and gas program, and to preserve the Arctic coastal plain of the Arctic National Wildlife Refuge, Alaska, as wilderness in recognition of its extraordinary natural ecosystems and for the permanent good of present and future generations of Americans. H.R. 544, Stop Arctic Ocean Drilling Act, all provisions -This bill declares that it is the policy of the United States that the Arctic Ocean should be managed for the best interests of the people of the United States, including by keeping fossil fuels in the ground to avoid the dangerous impacts of climate change. -The Outer Continental Shelf Lands Act is amended to prohibit the Department of the Interior from issuing or renewing a lease or any other authorization for the exploration, development, or production of oil, natural gas, or any other mineral in the Arctic Ocean, including the Beaufort Sea and Chukchi Sea Planning Areas. H.R. 279, S. 877, Roadless Area Conservation Act, all provisions -To provide lasting protection for inventoried roadless areas within the National Forest System. H.R. 3684 - Infrastructure Investment and Jobs Act -Alaska Wilderness League Action opposed section 40401(d) and supported amendment 2542 from Senate Markey to strip the language: ï‚§Markey Amendment 2542 strikes Sec. 40401(d) Loan Guarantees For Certain Alaska Natural Gas Transportation Projects and Systems, which would change the law to allow federal loan guarantees of approximately $25 billion dollars[1] to prop up the failing Alaska LNG Project, a $39 billion scheme to export North Slope natural gas to Asia and other foreign markets. H.R. 4502 -- Fiscal Year 2022 Labor-HHS-Education, Agriculture-Rural Development-FDA, Energy-Water, Financial Services and General Government, Interior-Environment, Military Construction-VA, Transportation-Housing and Urban Development Minibus -Alaska Wilderness League Action supported 1 provision in underlying bill: ï‚§The Tongass provision (Sec. 437 of Interior-Environment) would end taxpayer subsidies for any roadbuilding activity including design, study or construction of roads for logging in the Tongass National Forest in Southeast Alaska. For decades, the timber industry in the Tongass has quietly benefited from hundreds of millions of dollars in taxpayer subsidies, much of it covering costs associated with building logging roads that serve no public benefit. H.R. 5376 - Build Back Better Act -Alaska Wilderness League Action supports section 71201 in the underlying bill: ï‚§The section repeals the Arctic Refuge oil and gas program and cancel the leases issued under that program.
2021 · third_quarter · Environment/Superfund
S. 282, Arctic Refuge Protection Act, all provisions -This bill designates approximately 1,559,538 acres of land within Alaska in the Arctic National Wildlife Refuge (ANWR) as a component of the National Wilderness Preservation System. S. 1128, University of Alaska Fiscal Foundation Act, all provisions -This bill provides for the continuation of higher education through the conveyance to the University of Alaska of certain public land in the State of Alaska, and for other purposes. H.R. 815, Arctic Refuge Protection Act, all provisions -This bill amends Public Law 115-97 (commonly known as the Tax Cuts and Jobs Act) to repeal the Arctic National Wildlife Refuge oil and gas program, and to preserve the Arctic coastal plain of the Arctic National Wildlife Refuge, Alaska, as wilderness in recognition of its extraordinary natural ecosystems and for the permanent good of present and future generations of Americans. H.R. 544, Stop Arctic Ocean Drilling Act, all provisions -This bill declares that it is the policy of the United States that the Arctic Ocean should be managed for the best interests of the people of the United States, including by keeping fossil fuels in the ground to avoid the dangerous impacts of climate change. -The Outer Continental Shelf Lands Act is amended to prohibit the Department of the Interior from issuing or renewing a lease or any other authorization for the exploration, development, or production of oil, natural gas, or any other mineral in the Arctic Ocean, including the Beaufort Sea and Chukchi Sea Planning Areas. H.R. 279, S. 877, Roadless Area Conservation Act, all provisions -To provide lasting protection for inventoried roadless areas within the National Forest System. H.R. 3684 - Infrastructure Investment and Jobs Act -Alaska Wilderness League Action opposed section 40401(d) and supported amendment 2542 from Senate Markey to strip the language: ï‚§Markey Amendment 2542 strikes Sec. 40401(d) Loan Guarantees For Certain Alaska Natural Gas Transportation Projects and Systems, which would change the law to allow federal loan guarantees of approximately $25 billion dollars[1] to prop up the failing Alaska LNG Project, a $39 billion scheme to export North Slope natural gas to Asia and other foreign markets. H.R. 4502 -- Fiscal Year 2022 Labor-HHS-Education, Agriculture-Rural Development-FDA, Energy-Water, Financial Services and General Government, Interior-Environment, Military Construction-VA, Transportation-Housing and Urban Development Minibus -Alaska Wilderness League Action supported 1 provision in underlying bill: ï‚§The Tongass provision (Sec. 437 of Interior-Environment) would end taxpayer subsidies for any roadbuilding activity including design, study or construction of roads for logging in the Tongass National Forest in Southeast Alaska. For decades, the timber industry in the Tongass has quietly benefited from hundreds of millions of dollars in taxpayer subsidies, much of it covering costs associated with building logging roads that serve no public benefit. H.R. 5376 - Build Back Better Act -Alaska Wilderness League Action supports section 71201 in the underlying bill: ï‚§The section repeals the Arctic Refuge oil and gas program and cancel the leases issued under that program.
2021 · second_quarter · Environment/Superfund
S. 282, Arctic Refuge Protection Act, all provisions -This bill designates approximately 1,559,538 acres of land within Alaska in the Arctic National Wildlife Refuge (ANWR) as a component of the National Wilderness Preservation System. S. 1128, University of Alaska Fiscal Foundation Act, all provisions -This bill provides for the continuation of higher education through the conveyance to the University of Alaska of certain public land in the State of Alaska, and for other purposes. H.R. 815, Arctic Refuge Protection Act, all provisions -This bill amends Public Law 115-97 (commonly known as the Tax Cuts and Jobs Act) to repeal the Arctic National Wildlife Refuge oil and gas program, and to preserve the Arctic coastal plain of the Arctic National Wildlife Refuge, Alaska, as wilderness in recognition of its extraordinary natural ecosystems and for the permanent good of present and future generations of Americans. H.R. 544, Stop Arctic Ocean Drilling Act, all provisions -This bill declares that it is the policy of the United States that the Arctic Ocean should be managed for the best interests of the people of the United States, including by keeping fossil fuels in the ground to avoid the dangerous impacts of climate change. -The Outer Continental Shelf Lands Act is amended to prohibit the Department of the Interior from issuing or renewing a lease or any other authorization for the exploration, development, or production of oil, natural gas, or any other mineral in the Arctic Ocean, including the Beaufort Sea and Chukchi Sea Planning Areas. H.R. 279, S. 877, Roadless Area Conservation Act, all provisions -To provide lasting protection for inventoried roadless areas within the National Forest System. H.R. 4502 -- Fiscal Year 2022 Labor-HHS-Education, Agriculture-Rural Development-FDA, Energy-Water, Financial Services and General Government, Interior-Environment, Military Construction-VA, Transportation-Housing and Urban Development Minibus -Alaska Wilderness League Action supported 1 provision in underlying bill: -- The Tongass provision (Sec. 437 of Interior-Environment) would end taxpayer subsidies for any roadbuilding activity including design, study or construction of roads for logging in the Tongass National Forest in Southeast Alaska. For decades, the timber industry in the Tongass has quietly benefited from hundreds of millions of dollars in taxpayer subsidies, much of it covering costs associated with building logging roads that serve no public benefit.
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE